首页 » 未分类 » COVID-19: Vaccines are beginning to slow deaths among vulnerable, new research shows

COVID-19: Vaccines are beginning to slow deaths among vulnerable, new research shows

 
文章目录

There are early signs emerging in the COVID-19 data that vaccines are beginning to suppress deaths among the age groups most vulnerable to the virus.

Case fatality rates, which measure the percentage of people with confirmed COVID cases who eventually die, have dropped significantly for those aged 80 and over, according to new analysis based on recent weeks' data from Oxford University's Centre for Evidence Based Medicine.

The analysis, carried out by Daniel Howdon, Jason Oke and Carl Heneghan, found the case fatality rate (CFR) for those aged over 80 had dropped by around a third since early January.

While the CFR for those under 80 has also fallen, that fall was far smaller, at around 8%.

The data on the impact of the vaccines remains tentative, which is not unexpected since the first dose of the vaccines generally take a couple of weeks to be create an immune response, and because it would then take some weeks before the improvement in case load and mortality would be seen (since the virus takes time to spread and cause illness).

However, the analysis is perhaps a very early signal the vaccination campaign is beginning to deliver.

One of the authors of the analysis, Dr Daniel Howdon, said: "These results suggest larger falls in the fatality rate among age groups that were prioritised for vaccination, and are consistent with other tentative findings on the beginnings of an effect of vaccination in reducing severe COVID-19 health outcomes."

More on Covid

  • COVID-19: Vaccines are beginning to slow deaths among vulnerable, new research shows

COVID anniversary: Day of reflection across UK to mark five years since start of pandemic

  • COVID-19: Vaccines are beginning to slow deaths among vulnerable, new research shows
  • COVID scars remain in the tight-knit communities of Welsh Valleys

  • COVID-19: Vaccines are beginning to slow deaths among vulnerable, new research shows
  • Five years on from COVID, one survivor reflects on having to fight for his life

    Related Topics:

    • COVID
    • Coronavirus
    • Oxford-AstraZeneca vaccine
    • Pfizer-BioNTech vaccine